Tenofovir induced Fanconi syndrome in a middle age African female from Kenya, East Africa: Case report and brief literature review

被引：0
作者：
Odhiambo, Fredrick [1 ]
Nareeba, Shallot [1 ]
Mwangeka, Grace [1 ]
Njambi, Ann [1 ]
Nyakebati, Vashti [1 ]
机构：
[1] Maua Methodist Hosp, Meru, Kenya
来源：
CLINICAL CASE REPORTS | 2024年 / 12卷 / 06期
关键词：
antiretroviral therapy; drug induced nephrotoxicity; Fanconi syndrome; tenofovir; HIV-INFECTED PATIENTS; DISOPROXIL FUMARATE; INDUCED NEPHROTOXICITY; TUBULAR DYSFUNCTION; RENAL-FAILURE; SAFETY;
D O I：
10.1002/ccr3.8889
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This case presentation highlights the need to routinely monitor renal function in patients on Tenofovir Disoproxil Fumarate (TDF) due to its side effect of proximal tubule dysfunction.AbstractThis is a case presentation of a 50-year-old African female who had been on a Tenofovir based regimen for 12 years and developed Fanconi syndrome. She recovered after discontinuation of the Tenofovir Disoproxil Fumarate (TDF).
引用
收藏
页数：5
相关论文
共 31 条
  • [1] [Anonymous], 2018, UPDATED RECOMMENDATI
  • [2] Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
    Badiou, Stphanie
    De Boever, Corinne Merle
    Terrier, Nathalie
    Baillat, Vincent
    Cristol, Jean-Paul
    Reynes, Jacques
    [J]. JOURNAL OF INFECTION, 2006, 52 (05) : 335 - 338
  • [3] Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
    Brown, Todd T.
    McComsey, Grace A.
    King, Martin S.
    Qaqish, Roula B.
    Bernstein, Barry M.
    da Silva, Barbara A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (05) : 554 - 561
  • [4] Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients
    Cooper, Ryan D.
    Wiebe, Natasha
    Smith, Nathaniel
    Keiser, Philip
    Naicker, Saraladevi
    Tonelli, Marcello
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (05) : 496 - 505
  • [5] Tenofovir Nephrotoxicity: 2011 Update
    Fernandez-Fernandez, Beatriz
    Montoya-Ferrer, Ana
    Sanz, Ana B.
    Sanchez-Nino, Maria D.
    Izquierdo, Maria C.
    Poveda, Jonay
    Sainz-Prestel, Valeria
    Ortiz-Martin, Natalia
    Parra-Rodriguez, Alejandro
    Selgas, Rafael
    Ruiz-Ortega, Marta
    Egido, Jesus
    Ortiz, Alberto
    [J]. AIDS RESEARCH AND TREATMENT, 2011, 2011
  • [6] Fux CA, 2007, ANTIVIR THER, V12, P1165
  • [7] Tenofovir and bone health
    Grant, Philip M.
    Cotter, Aoife G.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2016, 11 (03) : 326 - 332
  • [8] Tenofovir treatment of primary osteoblasts alters gene expression profiles: Implications for bone mineral density loss
    Grigsby, Iwen F.
    Pham, Lan
    Mansky, Louis M.
    Gopalakrishnan, Raj
    Carlson, Ann E.
    Mansky, Kim C.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (01) : 48 - 53
  • [9] Low Socioeconomic Status Is Associated with Worse Survival in Children with Cancer: A Systematic Review
    Gupta, Sumit
    Wilejto, Marta
    Pole, Jason D.
    Guttmann, Astrid
    Sung, Lillian
    [J]. PLOS ONE, 2014, 9 (02):
  • [10] Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?
    Havens, Peter L.
    Kiser, Jennifer J.
    Stephensen, Charles B.
    Hazra, Rohan
    Flynn, Patricia M.
    Wilson, Craig M.
    Rutledge, Brandy
    Bethel, James
    Pan, Cynthia G.
    Woodhouse, Leslie R.
    Van Loan, Marta D.
    Liu, Nancy
    Lujan-Zilbermann, Jorge
    Baker, Alyne
    Kapogiannis, Bill G.
    Gordon, Catherine M.
    Mulligan, Kathleen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5619 - 5628
1234